Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AIBIOS Logo
AIBIOS Growth Score
62
CB Rank
108216
Heat Score
72
AIBIOS is a drug discovery and R&D biotech company with bioinformatics intelligence focusing on immune diseases.
Founded
obfuscation
PrivateSeed Irvine, California, United States11-50 www.aibios.com/
Bioinformatics
Biotechnology
Product Research
Overview

AIBIOS
Total Funding
obfuscation
Growth Score
62
Heat Score
72

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score62
25 pts
in past quarter
Heat Score 72
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AIBIOS

CB Rank
108216
AIBIOS is a drug discovery and R&D biotech company with bioinformatics intelligence focusing on immune diseases.
Founded
obfuscation
PrivateSeed Irvine, California, United States11-50 www.aibios.com/
Bioinformatics
Biotechnology
Product Research

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name AIBIOS Inc.
Also Known As AIB
Operating Status Active
Company Type For Profit
Founders  Akio Sato
About the Company
AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.
Phone Number +1 949-812-8023
Contact Email info@aibios.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

AIB-301
An oral small molecule drug candidate targeting immune system dysregulation to treat inflammatory bowel disease by modulating T cells and macrophages in the gut.
AIB-401
An oral small molecule drug candidate aimed at treating neuroinflammatory and autoimmune diseases by modulating inflammatory immune cells and reducing inflammation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed
obfuscation
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
1
obfuscation
SBI InvestmentSeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
SBI Investment Logo
SBI Investment
Yes
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
—
SBI Investment Logo
SBI Investment
Yes
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
—
SBI Investment Logo
SBI Investment
Yes
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
—
SBI Investment Logo
SBI Investment
Yes
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
—
SBI Investment Logo
SBI Investment
Yes
Seed Round - AIBIOS Logo
Seed Round - AIBIOS
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2

Employee Profiles

News

News and Press

News•Jul 31, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

3AIBIOS is actively using 3 technologies for its website, according to BuiltWith. These include U.S. Server Location and  Amazon.
Sub-Organizations
Frequently Asked Questions

Where is AIBIOS's headquarters? AIBIOS is located in Irvine, California, United States.Who invested in AIBIOS? AIBIOS is funded by SBI Investment.When was the last funding round for AIBIOS? AIBIOS closed its last funding round on
obfuscation
from a Seed round.Who are AIBIOS's competitors? Alternatives and possible competitors to AIBIOS may include Gilead Sciences, Abivax, and  Oruka Therapeutics.How much funding has AIBIOS raised to date? AIBIOS has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8b214dc 1)
|